Compare NSPR & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | HYPR |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.8M | 104.0M |
| IPO Year | N/A | N/A |
| Metric | NSPR | HYPR |
|---|---|---|
| Price | $2.01 | $1.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $4.00 | $1.28 |
| AVG Volume (30 Days) | 64.4K | ★ 763.0K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,779,000.00 | ★ $10,591,000.00 |
| Revenue This Year | $22.76 | $5.17 |
| Revenue Next Year | $75.45 | $35.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.04 | N/A |
| 52 Week Low | $1.59 | $0.53 |
| 52 Week High | $3.80 | $2.22 |
| Indicator | NSPR | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.94 | 50.17 |
| Support Level | $1.89 | $0.91 |
| Resistance Level | $2.17 | $1.18 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 50.00 | 55.56 |
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.